go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Shire Pharmaceuticals Ireland Limited
5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland,
Telephone: +353 1 429 7700
Fax: +353 1 429 7701
Medical Information Direct Line: 1 800 818 016
Medical Information e-mail: MedInfoIE@shire.com
Customer Care direct line: +44 (0)1256 894 107
Patient Information Leaflet last updated on medicines.ie: 06/06/2011
PIL Xagrid 0.5mg hard capsule

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 06/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to further information section
Updated on 17/05/2011 and displayed until 06/06/2011
Reasons for adding or updating:
  • Change to drug interactions
Updated on 28/02/2011 and displayed until 17/05/2011
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to name of manufacturer
  • Correction of spelling/typing errors
Updated on 08/12/2010 and displayed until 28/02/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change of distributor details
  • Correction of spelling/typing errors
Updated on 25/05/2010 and displayed until 08/12/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
Updated on 19/01/2010 and displayed until 25/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change of distributor details
Updated on 10/11/2009 and displayed until 19/01/2010
Reasons for adding or updating:
  • Change of contraindications
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change to dosage and administration
  • Change to MA holder contact details
  • Correction of spelling/typing errors
Updated on 06/03/2009 and displayed until 10/11/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Addition of marketing authorisation holder
  • Change to drug interactions
Updated on 10/12/2008 and displayed until 06/03/2009
Reasons for adding or updating:
  • Change to further information section
Updated on 01/10/2008 and displayed until 10/12/2008
Reasons for adding or updating:
  • Change to further information section
Updated on 20/02/2008 and displayed until 01/10/2008
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 07/06/2007 and displayed until 20/02/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 22/11/2006 and displayed until 07/06/2007
Reasons for adding or updating:
  • Change of contraindications
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
Updated on 09/03/2006 and displayed until 22/11/2006
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Anagrelide hydrochloride